The new C
1-symmetric complexes rac-[1-(9-η5-fluorenyl)-2-(2-methylbenz[e]-1-η5-indenyl)ethane]zirconium dichloride (14a), rac-[1-(9-η5-fluorenyl)-2-(4,5-cyclohexa-2-methyl-1-η5-indenyl)ethane]zirconium
dichloride (14b), and rac-[1-(9-η5-fluorenyl)-2-(5,6-cyclopenta-2-methyl-1-η5-indenyl)ethane]zirconium dichloride (15) were prepared in up to 93% yield. These compounds, activated with methyl aluminoxane, exhibit
high active propene polymerization rates which remain constant over hours, even at elevated polymerization
temperatures of 50 and 70 °C. The two different coordination sites of these “dual-side” catalysts lead to isotactic
polypropenes with variable amounts of stereoerrors, depending on the monomer concentration. The 2-methyl
substituent of the indenyl ligands results, at the same time, in significantly increased molecular weights of the
polymer products (up to 2.3 × 105 g mol-1), the bulk properties of which can be adjusted from flexible,
semicrystalline thermoplastic to excellent thermoplastic elastic.
SUMMARY: The polymerization behavior of three linear asymmetrically substituted dienes, i.e. 6-phenyl-1 ,5-hexadiene (A), 7-methyl-1,6-octadiene (B) and R(+)-5,7-dimethyl-1,6-0ctadiene (isocitronellene, C) is reported in order to study the effect of substitution at one vinylic group. Homopolymerization of these monomers with the catalyst system rac-Et[Ind]2ZrC12/MA0 resulted in no reaction products in the case of monomer A and in polymers with % , = 3.5 kg/mol and % = 14.0 kg/mol with the monomers B and C, respectively. According to NMR analysis, the vinylene end group of isocitronellene remained untouched during polymerization, which excludes the possibility of cyclopolymerization or crosslinking. Copolymerization of isocitronellene with propene resulted in incorporation of the diene (15.6 mol-%) equal to the stoichiometric ratio in the monomer feed, with a relatively high catalyst activity. The degree of incorporated isocitronellene is inversely related to the polymerization temperature, providing control over crystallinity (isotacticity) and molecular weight of the copolymer. The isocitronellene homo-and copolymers could be epoxidized quantitatively and brominated to an extent of 90%. Perfluorohexyl iodide was grafted onto the isocitronellene/propene copolymer by radical reaction (conversion 80%), yielding a poly(a-olefin) with fluorinated side chains.
Propene and 7-methyl-1,6-octadiene (MOD) were copolymerized with the catalyst system
rac-Et[Ind]2ZrCl2/MAO in semibatch reactions and under constant comonomer concentrations using an
autoclave setup that is equipped with an ATR-FTIR sensor coupled with a dosage system for the liquid
MOD comonomer. The concentration of the monomer propene is regulated precisely in both types of
polymerization by a gas flow controller. This setup enables to monitor the MOD concentration on-line
and in real-time during the reaction by following characteristic bands arising from the double bonds.
Copolymers with poorly defined incorporation data and thermal properties were obtained without control
of the MOD concentration in time. This is caused by a nonuniform distribution of the MOD units over
the polymer chains due to a relatively large shift of the MOD concentration during the copolymerization
reaction. By means of solvent extraction fractionation experiments, these copolymers could be fractionated
into three fractions with different amounts of incorporated MOD, varying from 11.5 to 7.2 mol %.
Functional copolymers with uniform architectures (up to 30.5 mol % incorporated MOD) were prepared
by using the on-line ATR-FTIR data to control the MOD concentration during the copolymerization
reactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.